This interaction prevents the binding of HuR to target mRNAs, such as Cyclin A2, Cyclin D1, SIRT1, VHL, TP53, and WEE1, and thereby inhibits the proliferation of cervical carcinoma cells [97]. This evidence concerns the gene TP53 and cervical carcinoma.